Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by L.V. Yegshatyan
Dulaglutide – New in the Treatment of Type 2 Diabetes
Effective Pharmacotherapy
Amiodarone-Induced Thyrotoxicosis Type 1: Features of Patient Management
Effective Pharmacotherapy
Related publications
Dulaglutide Slows Kidney Disease in Type 2 Diabetes
The Lancet
Medicine
Dulaglutide Slows Kidney Disease in Type 2 Diabetes − Author's Reply
The Lancet
Medicine
Dulaglutide: Third Once-Weekly GLP-1 Agonist for Type 2 Diabetes
Pharmacy Today
The Cost-Effectiveness of Dulaglutide Versus Liraglutide in Patients With Type 2 Diabetes Mellitus in Taiwan
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Efficacy and Safety of Dulaglutide in the Treatment of Type 2 Diabetes: A Comprehensive Review of the Dulaglutide Clinical Data Focusing on the AWARD Phase 3 Clinical Trial Program
Diabetes/Metabolism Research and Reviews
Internal Medicine
Endocrinology
Metabolism
Diabetes
Dapagliflozin: A New Adjunct in the Treatment of Type 2 Diabetes Mellitus
International Journal of Basic & Clinical Pharmacology
Treatment of Type 2 Diabetes in Youth
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
The Evolution of Type 2 Diabetes Treatment Approaches
Journal of Diabetes
Endocrinology
Metabolism
Diabetes
New Insights Into the Pharmacological Treatment of Pediatric Patients With Type 2 Diabetes
Clinical Pediatric Endocrinology
Child Health
Endocrinology
Perinatology
Pediatrics
Metabolism
Diabetes
